Literature DB >> 18603274

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.

Chung-Feng Huang1, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Sheng-Nan Lu, Ming-Yen Hsieh, Li-Po Lee, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang.   

Abstract

Tzukuan Township in Taiwan has been reported to be an endemic area for hepatitis C virus (HCV) infection both in adults and adolescents. The maritime part of the township carries a higher prevalence than the non-maritime part and, as a consequence, several public education strategies have been introduced during the past decade. The current follow-up study aimed to clarify the changing prevalence of HCV infection among teenagers in the endemic maritime part of Tzukuan. In addition to viral hepatitis markers and biochemical profiles, we compared the epidemiological characteristics of 887 and 394 teenagers (aged 13-16 years) from the maritime part enrolled in 1995 and 2005, respectively. Compared with the results of surveillance in 1995, the prevalence of anti-HCV seropositivity (1.0% vs. 2.8%; P=0.045) and HCV RNA (0.5% vs. 2.3%; P=0.026) had decreased significantly by 2005. Transfusions and anti-HCV-positive families were the main risk factors amongst the 25 anti-HCV-positive teenagers in 1995, and became non-significant amongst the four anti-HCV-positive teenagers in 2005. In conclusion, the seroprevalence of HCV infection has significantly decreased after one decade of intervention among the teenage population in this endemic area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603274     DOI: 10.1016/j.trstmh.2008.05.018

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Cohort study of familial viral hepatitis and risks of paediatric cancers.

Authors:  Julia E Heck; Chia-Kai Wu; Xiwen Huang; Kara W Chew; Myron Tong; Noah Federman; Beate Ritz; Onyebuchi A Arah; Chung-Yi Li; Fei Yu; Jorn Olsen; Johnni Hansen; Pei-Chen Lee
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

2.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

Review 3.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

4.  Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.

Authors:  Ming-Lung Yu; Ming-Lun Yeh; Pei-Chien Tsai; Ching-I Huang; Jee-Fu Huang; Chung-Feng Huang; Meng-Hsuan Hsieh; Po-Cheng Liang; Yi-Hung Lin; Ming-Yen Hsieh; Wen-Yi Lin; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.

Authors:  Tyng-Yuan Jang; Pei-Chin Lin; Ching-I Huang; Yu-Mei Liao; Ming-Lun Yeh; Yu-Sheng Zeng; Po-Cheng Liang; Wan-Yi Hsu; Shih-Pien Tsai; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Chung-Feng Huang; Shyh-Shin Chiou; Wan-Long Chuang; Ming-Lung Yu
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

6.  Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan.

Authors:  Pei-Chien Tsai; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Meng-Hsuan Hsieh; Jeng-Fu Yang; Po-Yao Hsu; Po-Cheng Liang; Yi-Hung Lin; Tyng Yuan Jang; Ming-Yen Hsieh; Chia-Yen Dai; Zu-Yau Lin; Shinn-Chern Chen; Jee-Fu Huang; Ming-Lung Yu; Wan-Long Chuang; Wen-Yu Chang
Journal:  BMJ Open       Date:  2021-03-15       Impact factor: 2.692

7.  Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).

Authors:  Jee-Fu Huang; Ming-Yen Hsieh; Yu-Ju Wei; Jen-Yu Hung; Hsuan-Ti Huang; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Tyng-Yuan Jang; Po-Yao Hsu; Po-Cheng Liang; Chia-Yen Dai; Zu-Yau Lin; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 9.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.